化学免疫疗法
医学
化疗
肺癌
癌症
队列
肿瘤科
回顾性队列研究
内科学
外科
环磷酰胺
作者
Yoko Tsukita,Takehiro Tozuka,Kohei Kushiro,Shinobu Hosokawa,Toshiyuki Sumi,Mao Uematsu,Osamu Honjo,Ou Yamaguchi,Tetsuhiko Asao,Jun Sugisaka,Go Saito,Jun Shiihara,Ryo Morita,Seigo Katakura,Takehiro Yasuda,Kakeru Hisakane,Eisaku Miyauchi,Satoshi Morita,Kunihiko Kobayashi,Hajime Asahina
出处
期刊:JAMA Oncology
[American Medical Association]
日期:2024-03-07
卷期号:10 (4): 439-439
被引量:3
标识
DOI:10.1001/jamaoncol.2023.6277
摘要
Immune checkpoint inhibitor (ICI) plus chemotherapy combination treatment (ICI-chemotherapy) is now a standard treatment for non-small cell lung cancer (NSCLC) without targetable oncogene alterations, but there are few data on ICI-chemotherapy for patients 75 years and older.
科研通智能强力驱动
Strongly Powered by AbleSci AI